GR3005276T3 - - Google Patents

Info

Publication number
GR3005276T3
GR3005276T3 GR920401606T GR920401606T GR3005276T3 GR 3005276 T3 GR3005276 T3 GR 3005276T3 GR 920401606 T GR920401606 T GR 920401606T GR 920401606 T GR920401606 T GR 920401606T GR 3005276 T3 GR3005276 T3 GR 3005276T3
Authority
GR
Greece
Prior art keywords
ulinastatin
platinum
side effects
kidney dysfunction
drugs
Prior art date
Application number
GR920401606T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005276T3 publication Critical patent/GR3005276T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920401606T 1988-02-08 1992-07-29 GR3005276T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63026918A JPH01203334A (ja) 1988-02-08 1988-02-08 白金を含有する薬剤の副作用軽減剤

Publications (1)

Publication Number Publication Date
GR3005276T3 true GR3005276T3 (el) 1993-05-24

Family

ID=12206574

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401606T GR3005276T3 (el) 1988-02-08 1992-07-29

Country Status (8)

Country Link
US (1) US4950465A (el)
EP (1) EP0327999B1 (el)
JP (1) JPH01203334A (el)
AT (1) ATE76754T1 (el)
AU (1) AU607584B2 (el)
CA (1) CA1329541C (el)
DE (1) DE68901656T2 (el)
GR (1) GR3005276T3 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE173627T1 (de) * 1992-09-04 1998-12-15 Fuji Chem Ind Co Ltd Medizinische zusammensetzung
CN1160123C (zh) 2003-05-26 2004-08-04 广东天普生化医药股份有限公司 乌司他丁用于治疗严重急性呼吸综合征的用途及其药物组合物
WO2018222656A1 (en) * 2017-05-30 2018-12-06 Zavante Therapeutics, Inc. Methods of identifying novel dosing regimens
US11725043B2 (en) 2020-03-05 2023-08-15 DiaMedica USA Inc. Ulinastatin polypeptides
WO2024111404A1 (ja) * 2022-11-21 2024-05-30 協和発酵バイオ株式会社 抗がん剤により誘発される急性腎障害の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028928A (ja) * 1983-07-27 1985-02-14 Meiji Seika Kaisha Ltd 制癌剤の副作用軽減剤
IT1200467B (it) * 1985-05-06 1989-01-18 Boehringer Biochemia Srl Formulazione farmaceutica
JPS62106021A (ja) * 1985-11-01 1987-05-16 Eisai Co Ltd エラスタ−ゼの利用方法

Also Published As

Publication number Publication date
JPH01203334A (ja) 1989-08-16
US4950465A (en) 1990-08-21
EP0327999A1 (en) 1989-08-16
EP0327999B1 (en) 1992-06-03
DE68901656T2 (de) 1993-02-11
DE68901656D1 (de) 1992-07-09
AU607584B2 (en) 1991-03-07
CA1329541C (en) 1994-05-17
JPH0560813B2 (el) 1993-09-03
ATE76754T1 (de) 1992-06-15
AU2955389A (en) 1989-08-10

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE68914856D1 (de) Synergetische Antioxydationsmischung.
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
CS404781A2 (en) Zpusob vyroby kyselin 3 (4 (2 hydroxy 3 isopropylaminopropoxy)fenyl)alkanovych
AU6569190A (en) Pharmaceutical compositions for treating gastrointestinal distress
GB8920805D0 (en) An anti-diabetic pharmaceutical composition
AU8188691A (en) The use of inositoltrisphosphate for the preparing of medicaments
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
CA2444071A1 (en) Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
MX9301707A (es) Composicion farmaceutica par inducir inmunosupresion.
GR3005276T3 (el)
GR3005870T3 (el)
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
GR3003790T3 (el)
NZ214103A (en) Antimicrobial composition; synergistic mixture of maduramicin and nicarbazin
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
JPS6431717A (en) Antitumor agent
IL85560A0 (en) Pharmaceutical compositions containing an antidepressant and a synergist
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
EP0335446A3 (en) Agents for treating neoplasms
EP0252305A3 (en) Use of avarone and avarol and derivatives thereof for the preparation of a pharmaceutical composition for the control of adult t-cell leukemia/lymphoma
DK0608648T3 (da) Højdoserede vitamin A-præparater
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments